CompletedPhase 4ACTRN12613000348752

The prophylactic use of a Bakri balloon for women undergoing caesarean section for placenta praevia – a randomised controlled trial

Amongst women undergoing caesarean section for placenta praevia does prophylacitc use of a Bakri intrauterine balloon immediately following delivery of placenta compared with usual measures reduce blood loss and/or the need for additional surgical/pharmacological measures to reduce blood loss


Sponsor

Michael Beckmann

Enrollment

100 participants

Start Date

Oct 1, 2009

Study Type

Interventional

Conditions

Summary

Placenta praevia remains a significant cause of peri-partum morbidity. It is associated with an increased risk of postpartum haemorrhage and subsequent surgical procedures to control bleeding including caesarean hysterectomy. The use of the Bakri balloon prophylactically at the time of caesarean section may provide a significant benefit in reducing blood loss and avoiding the need for other more extensive surgical procedures.


Eligibility

Sex: FemalesMin Age: 18 Yearss

Inclusion Criteria1

  • All women with live singleton pregnancies =24+0 weeks undergoing caesarean section in the setting of a known placenta praevia (leading edge of placenta <20mm from the cervical os) will be suitable for inclusion in this study

Exclusion Criteria8

  • Multiple pregnancy
  • Intrauterine Fetal Death
  • Suspected placenta accreta
  • Congenital abnormalities of the uterine cavity
  • Submucosal uterine fibroids >5cm
  • Women who give birth vaginally
  • Women aged <18 years
  • Inability to consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

For women randomised to the Bakri arm, the Bakri device package is opened following delivery of placenta and the stopcock removed from the inflation port at the end of the device. The balloon should

For women randomised to the Bakri arm, the Bakri device package is opened following delivery of placenta and the stopcock removed from the inflation port at the end of the device. The balloon should be placed (un-inflated) in the uterine cavity. Using a long Harrison forcep the inflation port end of the balloon device should be fed through the cervix from above and retrieved by an assistant (non-sterile) vaginally. The stopcock is then to be re-attached to the inflation port by the assistant. Meanwhile the first layer of closure of the uterine incision should be undertaken. Following this, 100ml of sterile water should be inflated into the Bakri balloon. The second layer uterine closure should now be performed taking care not to damage the underlying semi-inflated balloon device. After 2 layer uterine closure, the balloon device should be further inflated (up to a maximum total instilled volume of no more than 500ml) until the uterus is ‘firm’. In the event that the clinician is concerned regarding bleeding, any and all alternative surgical and/or pharmacological measures of achieving haemostasis can now be employed. This may include (but is not limited to) increased rate/duration/concentration of Syntocinon infusion, Misoprostol, Ergometrine, B-lynch or other compression suture, Ergometrine, PGF2-alpha, ligation of uterine/ovarian/internal iliac arteries, hysterectomy. At conclusion of the caesarean section, the surgeon should perform a vaginal examination to confirm that the balloon is in the uterine cavity. A Betadine soaked 1-inch vaginal pack should be introduced to reduce the risk of the balloon being expelled into the vagina. The urethral Foley catheter is to remain in situ until Bakri removed and subsequent vaginal loss assessed. The balloon device is to remain in-situ for no less than 17 hours and no more than 23 hours. The Bakri balloon should be deflated fully, but remain in-situ (deflated) for a further 1 hour to observe for ongoing blood loss in the Bakri collection bag. After 1 hour, the vaginal pack should be removed and the deflated Bakri balloon removed. Subsequent vaginal loss should be recorded up to 36 hours post-birth.


Locations(1)

Mater Mother's Hospital - South Brisbane

QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12613000348752